Systematic Identification of Familial Hypercholesterolaemia in Primary Care-A Systematic Review.

familial hypercholesterolaemia genetics primary care

Journal

Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269

Informations de publication

Date de publication:
15 Apr 2021
Historique:
received: 19 02 2021
revised: 24 03 2021
accepted: 10 04 2021
entrez: 30 4 2021
pubmed: 1 5 2021
medline: 1 5 2021
Statut: epublish

Résumé

Familial hypercholesterolaemia (FH) is a common inherited cause of premature cardiovascular disease, but the majority of patients remain undiagnosed. The aim of this systematic review was to assess the effectiveness of interventions to systematically identify FH in primary care. No randomised, controlled studies were identified; however, three non-randomised intervention studies were eligible for inclusion. All three studies systematically identified FH using reminders (on-screen prompts) in electronic health records. There was insufficient evidence that providing comments on laboratory test results increased the identification of FH using the Dutch Lipid Clinic Network (DLCN) criteria. Similarly, using prompts combined with postal invitation demonstrated no significant increase in definite FH identification using Simon-Broome (SB) criteria; however, the identification of possible FH increased by 25.4% (CI 17.75 to 33.97%). Using on-screen prompts alone demonstrated a small increase of 0.05% (95% CI 0.03 to 0.07%) in identifying definite FH using SB criteria; however, when the intervention was combined with an outreach FH nurse assessment, the result was no significant increase in FH identification using a combination of SB and DLCN criteria. None of the included studies reported adverse effects associated with the interventions. Currently, there is insufficient evidence to determine which is the most effective method of systematically identifying FH in non-specialist settings.

Identifiants

pubmed: 33920869
pii: jpm11040302
doi: 10.3390/jpm11040302
pmc: PMC8071332
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : Medical Research Council
ID : MR/T017384/1
Pays : United Kingdom
Organisme : National Institute for Health Research
ID : Cochrane Infrastructure funding to the Cochrane Cystic Fibrosis and Genetic Disorders Group

Références

Atherosclerosis. 2015 Nov;243(1):257-9
pubmed: 26408930
S Afr Med J. 1998 Dec;88(12):1569-74
pubmed: 9930253
BMJ. 1991 Oct 12;303(6807):893-6
pubmed: 1933004
Heart. 2016 Jun 1;102(11):855-61
pubmed: 26864669
J Clin Lipidol. 2017 Jul - Aug;11(4):1013-1022
pubmed: 28826564
Ann Clin Biochem. 2012 Nov;49(Pt 6):534-7
pubmed: 23002132
Atherosclerosis. 2018 Jul;274:54-60
pubmed: 29751285
Pathology. 2016 Aug;48(5):463-6
pubmed: 27328651
Atheroscler Suppl. 2017 Oct;29:25-30
pubmed: 28965617
BMJ. 2009 Jul 21;339:b2700
pubmed: 19622552
Eur Heart J. 2013 Dec;34(45):3478-90a
pubmed: 23956253
Br J Gen Pract. 2009 Oct;59(567):773-6
pubmed: 19765358
Circulation. 2015 Dec 1;132(22):2167-92
pubmed: 26510694
J Am Coll Cardiol. 2017 Oct 3;70(14):1732-1740
pubmed: 28958330
BMJ Open. 2017 Oct 22;7(10):e017539
pubmed: 29061621
Semin Vasc Med. 2004 Feb;4(1):59-65
pubmed: 15199434
Pathology. 2019 Feb;51(2):213-221
pubmed: 30579649
Heart Lung Circ. 2015 Mar;24(3):250-6
pubmed: 25445428
Lancet Public Health. 2019 May;4(5):e256-e264
pubmed: 31054643
J Pediatr Gastroenterol Nutr. 2009 Apr;48(4):456-63
pubmed: 19330934
Clin Chim Acta. 2015 Aug 25;448:18-21
pubmed: 26086446
J Clin Lipidol. 2016 Sep-Oct;10(5):1230-9
pubmed: 27678441
Clin Chim Acta. 2013 Jun 25;422:21-5
pubmed: 23566930
BMC Cancer. 2016 Oct 28;16(1):830
pubmed: 27793125
Heart Lung Circ. 2014 Dec;23(12):1153-7
pubmed: 25065543
J Clin Endocrinol Metab. 2012 Nov;97(11):3956-64
pubmed: 22893714
J Med Syst. 2017 Mar;41(3):45
pubmed: 28188559
Heart Lung Circ. 2017 May;26(5):450-454
pubmed: 27889294
Curr Atheroscler Rep. 2015;17(2):482
pubmed: 25612857
Eur Heart J. 2015 Sep 21;36(36):2438-45
pubmed: 26142466
QJM. 2020 Jun 1;113(6):411-417
pubmed: 31883017
N Engl J Med. 2016 Oct 27;375(17):1628-1637
pubmed: 27783906
Eur Heart J. 2011 Jul;32(14):1769-818
pubmed: 21712404
J Atheroscler Thromb. 2002;9(1):1-27
pubmed: 12238634
Heart. 2008 Jun;94(6):754-8
pubmed: 17575326
J Clin Lipidol. 2011 May-Jun;5(3):133-140
pubmed: 21600517
J Atheroscler Thromb. 2012;19(11):1019-26
pubmed: 23095241
Am J Cardiol. 1993 Jul 15;72(2):171-6
pubmed: 8328379
BMJ Open. 2016 May 26;6(5):e011734
pubmed: 27231005
J Eval Clin Pract. 2016 Jun;22(3):341-8
pubmed: 26608940
Atheroscler Suppl. 2011 Oct;12(2):221-63
pubmed: 21917530

Auteurs

Luisa Silva (L)

Primary Care Stratified Medicine (PRISM) Group, NIHR School of Primary Care Research, University of Nottingham, Nottingham NG7 2RD, UK.

Nadeem Qureshi (N)

Primary Care Stratified Medicine (PRISM) Group, NIHR School of Primary Care Research, University of Nottingham, Nottingham NG7 2RD, UK.

Hasidah Abdul-Hamid (H)

Primary Care Stratified Medicine (PRISM) Group, NIHR School of Primary Care Research, University of Nottingham, Nottingham NG7 2RD, UK.
Department of Primary Care Medicine, Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh 47000, Malaysia.

Stephen Weng (S)

Primary Care Stratified Medicine (PRISM) Group, NIHR School of Primary Care Research, University of Nottingham, Nottingham NG7 2RD, UK.

Joe Kai (J)

Primary Care Stratified Medicine (PRISM) Group, NIHR School of Primary Care Research, University of Nottingham, Nottingham NG7 2RD, UK.

Jo Leonardi-Bee (J)

Centre for Evidence Based Healthcare, Division of Epidemiology and Public Health, School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK.

Classifications MeSH